LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today it has introduced Pralatrexate Injection, a generic equivalent to Folotyn ®, for the treatment of relapsed or refractory peripheral T ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results